<DOC>
	<DOCNO>NCT01466712</DOCNO>
	<brief_summary>Inuvair® novel fix combination product use treatment asthma clinical development treatment COPD . Thanks extrafine particle size , able target whole bronchial tree , include small airway hence , expect act airway may thus beneficial COPD sense . In COPD , action small airway directly demonstrate thus far . By way contrast , dear evidence present treatment bronchodilator alone beneficially alter small airway function . The study hypothesis state effect inhale corticosteroid ICS/LABA combination small airway present objectivated .</brief_summary>
	<brief_title>Evaluate Effects Formoterol Beclomethasone Dipropionate Combination Therapy Small Airways Function</brief_title>
	<detailed_description />
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>clinical diagnosis COPD accord last updated GOLD guideline ( post bronchodilator FEV/FVC 0,70 , FEV1 &lt; 80 % predict ) exsmokers ( ie 1 year last cigarette ) least 10 pack year . GOLD stage II III ( FEV1 &gt; 30 % predict ) preference naïve inhaled corticosteroid ; take inhaled corticosteroid medication stop 1 month prior enrollment study Patients must prove small airway dysfunction routine spirometry reflect drop FEF2575 FEF75 least 50 % . Moreover , patient must prove small airway dysfunction MBW reflect Sacin &gt; 0,120 consider abnormal . Current smoke Active COPD exacerbation gold stage I IV</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>